Claire-Marie Rangon

Claire-Marie Rangon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claire-Marie Rangon has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vagus nerve–driven microbiota homeostasis: a promising integrative add-on therapy for neurodevelopmental disorders

    by Eric Azabou, Pierre-Yves Frouin, Marc Bellaïche, Irina Duff, Guillaume Bao, Amelie Pillot, Sara Mehlal, Jean Bergounioux, Peter S. Staats, Claire-Marie Rangon

    Over the past two decades, the conceptualization of neurodevelopmental disorders (NDDs) has undergone a profound transformation, shifting from a primarily brain-centric framework toward a systems-level perspective that integrates peripheral physiological processes. Among these, the gut microbiota has emerged as a critical determinant of neurodevelopmental trajectories. Through its involvement in immune modulation, metabolic signaling, and neural communication, the microbiota–gut–brain axis (MGBA) exerts a pervasive influence on brain maturation and function. A growing body of evidence indicates that early-life disruptions of microbiota composition—commonly referred to as dysbiosis—are associated with an increased risk of NDDs, including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and epilepsy. These disruptions are frequently driven by environmental exposures such as antibiotic use, cesarean delivery, dietary patterns, and psychosocial stress. Despite the expanding recognition of these associations, current therapeutic strategies aimed at restoring microbiota balance, including probiotics and fecal microbiota transplantation, have yielded inconsistent and often transient results. In this context, Vagus Nerve Stimulation (VNS), particularly in its non-invasive forms (nVNS), has emerged as a promising approach capable of modulating environmental exposures through the host-centered regulatory mechanisms of the MGBA. By influencing autonomic tone, activating the cholinergic anti-inflammatory pathway, and modulating neurotransmitter systems, nVNS may restore microbiota homeostasis while simultaneously improving neurodevelopmental outcomes. This article provides a comprehensive and integrative review of the mechanistic, preclinical, and clinical evidence supporting the role of nVNS as a microbiota-modulating intervention. We further discuss its potential as a safe, cost-effective and promising therapeutic strategy for neurodevelopmental disorders, with a particular emphasis on pediatric populations.

  • Open Access

    Clinical Advances in Child Neurology

    by Claire-Marie Rangon, Debopam Samanta

    When this Special Issue was launched, its initial aim was to gather innovative nonpharmacological therapeutic approaches for children with neurodevelopmental disorders

  • Open Access

    Editorial: Expanding therapeutic horizons with non-invasive vagus nerve stimulation

    by Claire-Marie Rangon, Jason Chen, Eric Azabou, Peter Staats

    The nervous system is fundamentally an electrical organ. Long before the molecular era, early physiologists recognized that bioelectric signals govern sensation, movement, and autonomic regulation. Today, advances in neuroscience, engineering, and clinical medicine are allowing us to return-more precisely and intentionally-to electricity as both a tool for understanding disease and a means to optimize human health and resilience. This special issue of Frontiers in Neuroscience, which we are honored to co-lead, explores the expanding therapeutic horizons of non-invasive vagus nerve stimulation (nVNS) as a cornerstone of this emerging bioelectric revolution.The vagus nerve occupies a singular position at the intersection of brain, body, and environment. As the principal conduit of bidirectional communication between the central nervous system and peripheral organs, it integrates autonomic control, immune modulation, metabolic regulation, circadian biology, and emotional state. Non-invasive approaches to vagus nerve stimulation now allow us to access this critical pathway safely, repeatably, and at scale-opening new possibilities not only for treating disease, but for restoring physiologic balance and promoting wellness. The contributions in this special issue reflect the remarkable breadth of conditions influenced by vagal signaling.First and foremost, the anti-inflammatory effect of vagus nerve stimulation, underscored more than 25 years ago by Kevin Tracey's team in Nature (Borovikova et al., 2000) is still making the front page of this prestigious journal (Jin et al., 2024). Initially invasive (VNS), devices have grown non-invasive (nVNS), becoming putatively available for a large number of patients unresponsive to conventional anti-inflammatory treatments. Far beyond the Cholinergic anti-inflammatory pathway (CAP) and neuro-immune reflexes, Liu et al., 2024 bring an up-to-date review of the mechanistic insights, including microbiota-vagus and mitochondria-vagus interactions, as well as future perspectives of nVNS, notably regarding precision neuromodulation (targeting distinct portions of the vagus nerve) and combination therapies, as seen below (J. Zhang et al., 2025).The anti-inflammatory properties of noninvasive vagus nerve stimulation are a recurring theme throughout the issue. Gargus et al., 2025 further examine neurodevelopmental disorders through the lens of early-life neuro-inflammation mediated by microglia, autonomic imbalance and disrupted neural connectivity. Non-invasive neuromodulation of brain plasticity offers a particularly compelling strategy in these populations, given its favorable safety profile and capacity for long-term use, not only regarding the neurological issues (epileptic encephalopathies) but also the psychiatric outcome (Autism Spectrum Disorders, Attention-Deficit/Hyperactivity Disorder or schizophrenia are tackled).Three other articles (two pilot studies and one protocol) further explore the role of nVNS in cognitive function in adult and elderly patients. The first article is a promising single-blind, sham-controlled, crossover study assessing the effect of off-line electrical transcutaneous auricular vagus nerve stimulation (taVNS) on a short-term memory task, suggesting an improvement during the encoding phase of the task (Fisicaro et al., 2025). The second one suggests that Vagus Nerve Magnetic modulation (VNMM) may be even more efficient than taVNS during dual-task paradigms, using functional near-infrared spectroscopy (fNIRS) (Wang et al., 2025). The third one describes a protocol for a randomized controlled trial investigating the effectiveness of a 4 week-treatment of combined rTMS and taVNS on 88 participants with mild cognitive impairment further followed up during 4 weeks (J. Zhang et al., 2025). These findings suggest applications that extend beyond traditional neurological disease into cognitive optimization and healthy aging.Similarly, emerging data in sleep regulation (Zhou et al., 2025) and melatonin secretion (Y. Zhang et al., 2024) point to vagal modulation as a means of restoring circadian harmony-an increasingly urgent need in a world characterized by sleep disruption and comorbid chronic illness involving gut-brain interaction like dyspepsia (Zhou et al., 2025) or blood glucose regulation (J. Zhang et al., 2025). By modulating vagal afferent and efferent pathways, nVNS demonstrates the potential to recalibrate gastric motility, visceral sensitivity, and central processing of interoceptive signals. These studies underscore the vagus nerve's role as a therapeutic bridge between neuroscience and gastroenterology.Cardiometabolic health represents another critical frontier. Contributions addressing atrial fibrillation (Jiang et al., 2025) and type 2 diabetes (Staats et al., 2025) illustrate how vagal tone can influence cardiac electrophysiology, insulin sensitivity, and metabolic homeostasis. These findings challenge the traditional separation of neurological and systemic disease, reinforcing the concept that combined neuromodulation can serve as a unifying long-term therapeutic strategy across organ systems (Staats et al., 2025), contrary to new drugs like Glucagon Like Peptide-1 agonists whose effects do not last (Wilding et al., 2022).Last but not least, nVNS holds promise for not only chronic disorders but also for acute surgery like post-operative pain management of open fractures, a case report by (Li et al., 2025) or postoperative fatigue syndrome in particularly frail elderly patients with cancer, a clinical hypothesis study by (Yin et al., 2025), as a complementary strategy.Collectively, these articles signal a paradigm shift. Non-invasive vagus nerve stimulation is no longer confined to a narrow set of indications; it is emerging as a platform technology for bioelectronic medicine. Importantly, this field invites a new model of care-one that complements pharmacology rather than replaces it, prioritizes physiologic...


  • Open Access

    Is vagus nerve-mediated regulation of immunity an etiological target for therapeutic intervention in endometriosis?

    by Claire-Marie Rangon, Shaoyuan Li, Peter S. Staats, Alba Boluda-Nicola, Jérôme Bouaziz

    Endometriosis is a complex chronic neuro-inflammatory disorder, affecting roughly 10% of reproductive-age women. It is characterized by the presence of endometrial-like tissue outside the uterus, which induces a chronic inflammatory reaction. This disease can present a wide range of symptoms, including chronic pain and infertility. Despite extensive research, the exact pathogenesis of endometriosis remains incompletely understood. New strategies and paradigms on pathogenesis and treatment are needed. Schematic factors contributing to the development of endometriosis lesions include genetic, hormonal, and immunological factors. Although genetics may contribute to the epidemiologically suggested heritability of endometriosis, epigenetics has gained an increasing consideration in research. Remarkably, microbiota dysbiosis, acting as a catalyst for the main acknowledged epigenetic etiologies (locally produced estradiol, pro-inflammatory cytokines, and hypoxic stress) demands further attention. Indeed, over the past 10 years, it has become clear that the vagus nerve, the fastest component of the microbiota-gut-brain axis, can efficiently control inflammation through the cholinergic anti-inflammatory pathway. Therefore, stimulation of the vagus nerve could be a good candidate for modulating the severity of endometriosis. The detrimental consequences of microbiome dysbiosis and the estrobolome activity on the initiation of the disease as well as counterpart dysfunctions in the central nervous system will be focused on, both supporting a key role of the vagus nerve since the early stage of endometriosis. Consequently, the rationale for using non-invasive vagus nerve stimulation will be discussed, introducing a fruitful shift of paradigm in this still enigmatic disease.

  • Open Access

    Global solutions for long COVID: The necessity of sustainable vagal tone restoration

    by Claire-Marie Rangon, Peter Staats

    AccScience Publishing is a publishing company based in Singapore. We have in our portfolio a range of high-quality, open-access, peer-reviewed journals and books from a broad spectrum of science, technology, biomedicine, engineering, education, social sciences and many more.

  • Open Access

    Transcutaneous auricular vagus nerve stimulation improves gastric motility and visceral hypersensitivity in rodents of functional dyspepsia by balancing duodenal immune response: an experimental study

    by Shaoyuan Li, Ningyi Bs Zou, Bowen Feng, Claire Marie Rangon, Juan Han, Lin Wang, Yang Yang, Wei Wei, Peijing Rong

    An abstract is unavailable. This article is available as a PDF only.


  • Top Cited Papers
    Open Access

    Transcutaneous auricular vagus nerve stimulation as a novel therapy connecting the central and peripheral systems: a review

    by Ningyi Bs Zou, Qing Bs Zhou, Yuzhengheng Bs Zhang, Chen Xin, Yifei Wang, Rangon Claire-Marie, Peijing Rong, Guojian Gao, Shaoyuan Li

    Currently, clinical practice and scientific research mostly revolve around a single disease or system, but the single disease-oriented diagnostic and therapeutic paradigm needs to be revised. This review describes how transcutaneous auricular vagus nerve stimulation (taVNS), a novel non-invasive neuromodulation approach, connects the central and peripheral systems of the body. Through stimulation of the widely distributed vagus nerve from the head to the abdominal cavity, this therapy can improve and treat central system disorders, peripheral system disorders, and central-peripheral comorbidities caused by autonomic dysfunction. In the past, research on taVNS has focused on the treatment of central system disorders by modulating this brain nerve. As the vagus nerve innervates the heart, lungs, liver, pancreas, gastrointestinal tract, spleen and other peripheral organs, taVNS could have an overall modulatory effect on the region of the body where the vagus nerve is widespread. Based on this physiological basis, the authors summarize the existing evidence of the taVNS ability to regulate cardiac function, adiposity, glucose levels, gastrointestinal function, and immune function, among others, to treat peripheral system diseases, and complex diseases with central and peripheral comorbidities. This review shows the successful examples and research progress of taVNS using peripheral neuromodulation mechanisms from more perspectives, demonstrating the expanded scope and value of taVNS to provide new ideas and approaches for holistic therapy from both central and peripheral perspectives.


  • Open Access

    Benefit of noninvasive vagus nerve stimulation in vaccine optimization for young children

    by Claire-Marie Rangon, Peter Staats

    Whether it is mandatory to vaccinate young children against SARS-CoV-2 and respiratory syncytial virus (RSV) is still an ongoing topic of debate. Indeed, vaccine acceptance for young children is either too low (in the case of COVID-19) or, in some cases, unattainable (with the demand far exceeding the capacity of production in the case of RSV vaccines in some countries). In addition, while vaccines do confer immunity, they can be complicated by inflammatory reactions to the vaccine itself. This inflammatory response is controlled by the nervous system, specifically the vagus nerve. Vagal tone optimization in and of itself confers some level of protection against viral infections such as SARS-CoV-2 or RSV, but the degree of protection has not been adequately evaluated. Even though additional studies are needed to validate a strategy of vagal optimization as an alternative to or co-treatment with vaccines, studies of noninvasive vagus nerve stimulation should be supported by public health agencies as an adjunctive tool providing young children with safe, ready-to-use immunization and protection from vaccine reactions. This recommendation is based on scientific, epidemiological, ethical, and economic considerations.


  • Open Access

    Report from the 11th International Symposium on Auriculotherapy Held in Copenhagen, 8-10 September 2023 - Auriculotherapy meets the field of Psychology

    by Claire Marie Rangon, Gerhard Litscher, Robert Bering, Gary Stanton, Anne Marie Bering, Stephen W. Porges, Raphaël Nogier

    Conference ReportReport from the 11th International Symposium on Auriculotherapy Held in Copenhagen, 8-10 September 2023 - Auriculotherapy meets the field of PsychologyClaire Marie Rangon 1, Gerhard Litscher 2, *, Robert Bering 3, Gary Stanton 4, Anne Marie Bering 5, Stephen W. Porges 6, 7, Raphaël Nogier 8* Correspondence: Gerhard Litscher; E-Mail: gerhard.litscher@medunigraz.atOBM Integrative and Complementary Medicine2023, volume 8, issue 4doi:10.21926/obm.icm.2304047Received: October 19, 2023Accepted: October 25, 2023Published: October 26, 2023


  • Open Access

    Editorial: Vagus nerve-mediated drive in supporting homeostasis: optimizing global health through monitoring and stimulating vagal function

    by Claire Marie Rangon, Adam Niezgoda, Emmanuel Moyse, Stephen W. Porges

    Editorial: Vagus nerve-mediated drive in supporting homeostasis: optimizing global health through monitoring and stimulating vagal function